EA200100801A1 - Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения - Google Patents

Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения

Info

Publication number
EA200100801A1
EA200100801A1 EA200100801A EA200100801A EA200100801A1 EA 200100801 A1 EA200100801 A1 EA 200100801A1 EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A1 EA200100801 A1 EA 200100801A1
Authority
EA
Eurasian Patent Office
Prior art keywords
manufacture
treatment
pharmaceutical composition
nazal
uterine bleeding
Prior art date
Application number
EA200100801A
Other languages
English (en)
Russian (ru)
Inventor
Яннис Тсудеро
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200100801A1 publication Critical patent/EA200100801A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
EA200100801A 1999-03-31 2000-03-30 Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения EA200100801A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (fr) 1999-03-31 1999-03-31 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
PCT/FR2000/000790 WO2000059447A2 (fr) 1999-03-31 2000-03-30 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables

Publications (1)

Publication Number Publication Date
EA200100801A1 true EA200100801A1 (ru) 2002-04-25

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100801A EA200100801A1 (ru) 1999-03-31 2000-03-30 Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения

Country Status (16)

Country Link
EP (1) EP1143978A2 (zh)
JP (1) JP2002541076A (zh)
KR (1) KR20010102464A (zh)
CN (1) CN1346273A (zh)
AU (1) AU3662300A (zh)
BR (1) BR0008577A (zh)
CA (1) CA2361885A1 (zh)
EA (1) EA200100801A1 (zh)
FR (1) FR2791572A1 (zh)
HK (1) HK1044486A1 (zh)
HU (1) HUP0200244A3 (zh)
NO (1) NO20014022D0 (zh)
NZ (1) NZ513672A (zh)
PL (1) PL356767A1 (zh)
WO (1) WO2000059447A2 (zh)
ZA (1) ZA200106689B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
EP0914165B1 (en) * 1996-07-23 2006-10-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms

Also Published As

Publication number Publication date
JP2002541076A (ja) 2002-12-03
WO2000059447A3 (fr) 2001-04-26
AU3662300A (en) 2000-10-23
EP1143978A2 (fr) 2001-10-17
ZA200106689B (en) 2002-11-14
KR20010102464A (ko) 2001-11-15
NO20014022L (no) 2001-08-17
FR2791572A1 (fr) 2000-10-06
CN1346273A (zh) 2002-04-24
HK1044486A1 (zh) 2002-10-25
HUP0200244A2 (hu) 2002-07-29
HUP0200244A3 (en) 2003-05-28
PL356767A1 (en) 2004-07-12
WO2000059447A2 (fr) 2000-10-12
NZ513672A (en) 2001-09-28
NO20014022D0 (no) 2001-08-17
CA2361885A1 (fr) 2000-10-12
BR0008577A (pt) 2002-10-01

Similar Documents

Publication Publication Date Title
EA200201000A1 (ru) Гормон-заместительная терапия
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
EA200301022A1 (ru) Гормональная заместительная терапия
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
WO2001076638A3 (en) Compositions for drug delivery
EE05259B1 (et) Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks
ATE289293T1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
GB2368525A (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
EA200301023A1 (ru) Заместительная терапия эстрогенами
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EA200100828A1 (ru) 16-гидроксиэстратриены в качестве эстрогенов избирательного действия
ATE252910T1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
DK1343472T3 (da) Thixotropisk næsespray
EA200100801A1 (ru) Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения
EA200200284A1 (ru) Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента женских контрацептивов
EA200601089A1 (ru) Трансдермальная доставка гормонов без необходимости использования агентов, усиливающих проникновение
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
EP0902025A3 (en) Benzothiophenes for treatment of estrogen related conditions
ATE371737T1 (de) Proteaseresistente flint-analoge
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
ATE307144T1 (de) Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauen
ATE263164T1 (de) Bentzothiophene
UA68381C2 (en) Spermicidal substance and vaginal contraceptive